The Federal Circuit Bar Association (FCBA) will be offering a program on "The Evolving Scope of IPR Estoppel" on March 29, 2018 from 1:00 pm to 2:00 pm (EST) at the FCBA office in Washington, DC. Eldora Ellison of Sterne Kessler Goldstein & Fox, PLLC will moderate a panel consisting of Brian Walsh of Bristol-Myers Squibb Company, Andrew Trask of Google LLC, and Jonathan Strang of Latham & Watkins LLP. The panel will provide an overview of the current state of estoppels following IPRs, and also consider the impact that the evolution of the application of the AIA's estoppel provisions…Original Article
You may also like
Pharmaceutical Sales Customer Engagement –...
AstraZeneca’s Polyneuropathy Treatment Recommended...
Designing a Strategic Roadmap for Seamless Product...
AAPS PharmSci 360: LBFs and Tackling Oral Biologic...
CHMP Gives Positive Opinion to Novo Nordisk Hemophilia...
GSK, Cambridge to Partner on R&D for Kidney and...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.